文献速递神经肿瘤

抑制突变PPM1D增强弥漫内生型脑桥胶质瘤的DNA损伤反应与放疗生长抑制效应

Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
PubMed 文献 · Neuro Oncol · 2019-01-01

研究探讨PPM1D突变(见于高达25%的DIPG病例)在DIPG发病与治疗中的作用,采用遗传和药理学方法在体外、脑切片及小鼠模型中验证。结果显示PPM1D突变通过稳定截短蛋白、灭活p53和H2A.X促进肿瘤生长并缩短小鼠生存,而抑制PPM1D可激活DNA损伤反应并增强放疗的抗增殖与促凋亡效应。

要点

  • PPM1D突变通过稳定截短蛋白灭活p53和H2A.X,促进DIPG增殖并缩短小鼠生存。
  • PPM1D敲低或抑制剂抑制突变型DIPG生长,减少增殖、增加凋亡并延长小鼠生存。
  • PPM1D抑制增强放疗对突变型DIPG的抗增殖与促凋亡效应。

核心结论

  • PPM1D突变灭活DNA损伤反应并促进DIPG生长。
  • PPM1D抑制剂激活DNA损伤反应通路并增强放疗在DIPG模型中的抗增殖与促凋亡效应。
  • 结果支持继续开发PPM1D抑制剂用于DIPG儿童的I/II期试验。

研究设计与样本

  • 采用遗传和药理学方法,检测PPM1D突变对DIPG生长和小鼠生存的影响。
  • 在患者来源DIPG细胞体外、器官型脑切片及体内模型中,检测靶向突变PPM1D单用或联合放疗对信号、细胞周期、增殖和凋亡的影响。

主要发现

  • PPM1D突变型DIPG细胞系在体外和体内增殖增加,经原位异种移植小鼠生存缩短。
  • PPM1D敲低或PPM1D抑制剂在体外抑制PPM1D突变型DIPG生长。
  • 将PPM1D短发夹RNA转导或PPM1D抑制剂处理的PPM1D突变型DIPG细胞原位异种移植至免疫缺陷小鼠,肿瘤增殖减少、凋亡增加、小鼠生存延长。
  • PPM1D抑制对DIPG生长的抑制效果与单用放疗相似,并增强放疗在PPM1D突变型DIPG模型中的抗增殖和促凋亡效应。

临床怎么用

  • PPM1D突变见于高达25%的DIPG病例,可作为治疗靶点探索。
  • PPM1D抑制剂联合放疗在DIPG模型中显示增强效应,支持开展I/II期临床试验。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Children with diffuse intrinsic pontine glioma (DIPG) succumb to disease within 2 years of diagnosis despite treatment with ionizing radiation (IR) and/or chemotherapy. Our aim was to determine the role of protein phosphatase, magnesium-dependent 1, delta (PPM1D) mutation, present in up to 25% of cases, in DIPG pathogenesis and treatment. METHODS: Using genetic and pharmacologic approaches, we assayed effects of PPM1D mutation on DIPG growth and murine survival. We assayed effects of targeting mutated PPM1D alone or with IR on signaling, cell cycle, proliferation, and apoptosis in patient-derived DIPG cells in vitro, in organotypic brain slices, and in vivo. RESULTS: PPM1D-mutated DIPG cell lines exhibited increased proliferation in vitro and in vivo, conferring reduced survival in orthotopically xenografted mice, through stabilization of truncated PPM1D protein and inactivation of DNA damage response (DDR) effectors p53 and H2A.X. PPM1D knockdown or treatment with PPM1D inhibitors suppressed growth of PPM1D-mutated DIPGs in vitro. Orthotopic xenografting of PPM1D short hairpin RNA-transduced or PPM1D inhibitor-treated, PPM1D-mutated DIPG cells into immunodeficient mice resulted in reduced tumor proliferation, increased apoptosis, and extended mouse survival. PPM1D inhibition had similar effects to IR alone on DIPG growth inhibition and augmented the anti-proliferative and pro-apoptotic effects of IR in PPM1D-mutated DIPG models. CONCLUSIONS: PPM1D mutations inactivate DDR and promote DIPG growth. Treatment with PPM1D inhibitors activated DDR pathways and enhanced the anti-proliferative and pro-apoptotic effects of IR in DIPG models. Our results support continued development of PPM1D inhibitors for phase I/II trials in children with DIPG.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Akamandisa MP, Nie K, Nahta R, et al. Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma. Neuro Oncol. 2019. PMID: 30852603. doi:10.1093/neuonc/noz053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。